Research & Development is the key to the future of pharmaceutical industry. The
pharmaceutical advances for considerable improvement in life expectancy and health all over the
world are the result of a steadily increasing investment in research. There is considerable scope
for collaborative R & D in India.
India can offer several strengths to the international R&D community. These strengths relate to availability of excellent scientific talents who can develop combinatorial chemistry, new synthetic molecules and plant derived candidate drugs.
Klintoz Pharmaceutical Pvt. Ltd. , is dedicated to discovering and developing innovative medicines and making them available to people around the world. Our business is fundamentally about saving, improving and enhancing lives, and we believe that by being successful as a business we provide the greatest benefit to society.
Klintoz Pharmaceutical Pvt. Ltd., with its rich scientific talents, provides cost-effective clinical trial research. It has an excellent record of development of improved, cost-beneficial chemical syntheses for various drug molecules.
We believe that networking in R&D is key for accelerated progress. We have developed major strengths
in the areas of Chemical Research, Bio-equivalent generics and Novel Drug Delivery System (NDDS).
We have taken initiatives to create infrastructure and capabilities in the area of New Drug Discovery Research. We have state-of-art research and development Facilities at our R&D Center.
Our Formulation Development Laboratory has been gearing up for a state-of-the-art R&D facility (in line with the US-FDA requirements). The laboratory is well equipped with various ultramodern equipments and technologies required for conducting high quality research activities.
SOME OF THE EQUIPMENTS AVAILABLE IN THE R&D ARE:
The key activities of R & D Formulation are:
Novel Drug Delivery System (NDDS):
R & D in this area attempts to improve the efficiency with which the medicine is absorbed in the body. Novel Drug Delivery Systems (NDDS) efforts are directed towards:
Klintoz's Research concentrates on sustained, delayed and pulsatile release. The company introduced a novel bilayer tablet for an antidiabetic combination.
Novel Dosage Formulations:
In the novel dosage form, the company concentrates on the following therapeutic segments.
Copyright 2022-2023 Klintoz Pharmaceuticals Pvt. Ltd., Content All Right Reserved
Website Visitor Counter : Loading...